Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
- PMID: 24929223
- DOI: 10.1016/j.drudis.2014.06.002
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
Abstract
The pharmacokinetics (PK), metabolism and biodistribution of polyethylene glycol (PEG) in PEGylated proteins are important to understand the increased cellular vacuolation reported in various tissues in animals. The tissue distribution profile of PEGylated proteins and 'metabolic' PEG is guided largely by absolute PEG load, PEG molecular weight and, where applicable, receptor-mediated uptake via the protein moiety. High molecular weight PEGs show slow renal clearance, and consequently have a greater potential to accumulate within cells. The intracellular nonbiodegradable PEG can accumulate within the lysosome ultimately causing distension and vacuolation observed by standard histological examinations. Improved bioanalytical methodologies will contribute to the identification of specific PK parameters including distribution behavior to support development of PEGylated proteins as therapeutics.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
High molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteins.Toxicol Pathol. 2013;41(7):970-83. doi: 10.1177/0192623312474726. Epub 2013 Jun 20. Toxicol Pathol. 2013. PMID: 23788571
-
Tumor uptake of pegylated diabodies: Balancing systemic clearance and vascular transport.J Control Release. 2018 Jun 10;279:126-135. doi: 10.1016/j.jconrel.2018.04.013. Epub 2018 Apr 11. J Control Release. 2018. PMID: 29653224
-
Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.Anticancer Res. 2009 Jun;29(6):2111-20. Anticancer Res. 2009. PMID: 19528471
-
Obstacles and pitfalls in the PEGylation of therapeutic proteins.Curr Opin Drug Discov Devel. 2008 Mar;11(2):242-50. Curr Opin Drug Discov Devel. 2008. PMID: 18283612 Review.
-
PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies.Drug Metab Dispos. 2007 Jan;35(1):9-16. doi: 10.1124/dmd.106.012419. Epub 2006 Oct 4. Drug Metab Dispos. 2007. PMID: 17020954 Review.
Cited by
-
Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.Mol Biotechnol. 2017 Oct;59(9-10):374-384. doi: 10.1007/s12033-017-0026-7. Mol Biotechnol. 2017. PMID: 28721592
-
Tuning protein half-life in mouse using sequence-defined biopolymers functionalized with lipids.Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2103099119. doi: 10.1073/pnas.2103099119. Proc Natl Acad Sci U S A. 2022. PMID: 35046019 Free PMC article.
-
Heparosan-coated liposomes for drug delivery.Glycobiology. 2017 Nov 1;27(11):1062-1074. doi: 10.1093/glycob/cwx070. Glycobiology. 2017. PMID: 29044377 Free PMC article.
-
Probiotic Activity of Staphylococcus epidermidis Induces Collagen Type I Production through FFaR2/p-ERK Signaling.Int J Mol Sci. 2021 Jan 31;22(3):1414. doi: 10.3390/ijms22031414. Int J Mol Sci. 2021. PMID: 33572500 Free PMC article.
-
PEG300 Protects Mitochondrial Function By Upregulating PGC-1α to Delay Central Nervous System Oxygen Toxicity in Mice.Neurotox Res. 2024 Jun 17;42(4):30. doi: 10.1007/s12640-024-00708-0. Neurotox Res. 2024. PMID: 38884699
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources